TENAX THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
TENAX THERAPEUTICS, INC. (TENX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2024-03-28
- TENAX THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2022-12-31 was $27.86K.
- TENAX THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- TENAX THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $108.19K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | ||
| 2022-12-31 | $27.86K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $108.19K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $80.33K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |